跳至主要内容
临床试验/NCT06906042
NCT06906042招募中不适用

Multimodal Cardiovascular and Hepatic Population Imaging

Institut National de la Santé Et de la Recherche Médicale, France1 个研究点 分布在 1 个国家目标入组 2,400 人开始时间: 2025年9月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
2,400
试验地点
1
主要终点
Establishement of reference nomograms accounting for sex in diaphragm

研究概览

简要总结

Medical imaging is increasingly important for understanding diseases, detecting them early, and personalizing treatments. New imaging techniques, which can measure processes in the body without surgery, are opening the door to a more precise approach to medicine. Instead of relying on general probabilities, this technology allows us to analyze specific factors in a person's health, leading to better predictions and targeted treatments. One key challenge in medicine today is reducing "residual individual risk"-the remaining health risks that current treatments don't fully address. This involves understanding how factors like age, sex, genetics, and environment affect our health, particularly when it comes to conditions like heart and liver disease. By using imaging to distinguish between normal aging and disease, we can better assess individual health risks.

The current project will create a large collection of medical images linked with health data from a broad population across France. Using advanced, non-invasive techniques such as MRI and ultrasound, researchers will analyze the heart, blood vessels, and liver in detail, considering factors like gender and health risk profiles. This will help improve our understanding of these diseases, which are often silent and not well understood, providing direct benefits to the participants. Ultimately, the goal is to optimize imaging technologies for large-scale studies, which will help enhance early detection and prevention for everyone.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Participation to the Constances cohort
  • •Age ≥ 20 years
  • •No overt cardiovascular or hepatic disease or related symptoms
  • •No known family or personal genetic disease
  • •Affiliation with a social security scheme or beneficiary of such a scheme.
  • •Agreement to sign the consent

排除标准

  • •Renal function impairment with GFR < 60 mL/min/1.73m2
  • •Deprived of liberty or persons subject to a legal protection measure (under guardianship or trusteeship)
  • •People with contraindications to MRI (claustrophobia, presence of metallic elements…)
  • •Pregnant or breastfeeding woman (pregnancy urinary test before inclusion for women of childbearing age).

研究组 & 干预措施

Constances volunteers

The 2400 volunteers will be stratifed according to age in decades from 20 to 80 years of age and matched 1:1 male:female.

干预措施: Imaging examinations (Radiation)

Constances volunteers

The 2400 volunteers will be stratifed according to age in decades from 20 to 80 years of age and matched 1:1 male:female.

干预措施: Paramedical examinations (Other)

Constances volunteers

The 2400 volunteers will be stratifed according to age in decades from 20 to 80 years of age and matched 1:1 male:female.

干预措施: Medical examination (Other)

Constances volunteers

The 2400 volunteers will be stratifed according to age in decades from 20 to 80 years of age and matched 1:1 male:female.

干预措施: Echocardiography (Other)

结局指标

主要结局

Establishement of reference nomograms accounting for sex in diaphragm

时间窗: During 36 months of analysis (after 60 months of inclusion)

Ultrasound and MRI images analysis of diaphragm

Establishement of reference nomograms accounting for age in diaphragm

时间窗: During 36 months of analysis (after 60 months of inclusion)

Ultrasound and MRI images analysis of diaphragm

Establishement of reference nomograms accounting for sex in kidney

时间窗: During 36 months of analysis (after 60 months of inclusion)

Ultrasound and MRI images analysis of kidney

Establishement of reference nomograms accounting for age in heart

时间窗: During 36 months of analysis (after 60 months of inclusion)

Ultrasound and MRI images analysis of qualitative and quantitative morphology, function, quantitative tissue characterization of the heart

Establishement of reference nomograms accounting for sex in heart

时间窗: During 36 months of analysis (after 60 months of inclusion)

Ultrasound and MRI images analysis of qualitative and quantitative morphology, function, quantitative tissue characterization of the heart

Establishement of reference nomograms accounting for age in liver

时间窗: During 36 months of analysis (after 60 months of inclusion)

Ultrasound and MRI images analysis of quantitative steatosis, fibrosis

Establishement of reference nomograms accounting for sex in liver

时间窗: During 36 months of analysis (after 60 months of inclusion)

Ultrasound and MRI images analysis of quantitative steatosis, fibrosis

Establishement of reference nomograms accounting for age in adipose tissue

时间窗: During 36 months of analysis (after 60 months of inclusion)

Ultrasound and MRI images analysis of volumes of subcutaneous, visceral and epicardial adipose tissues

Establishement of reference nomograms accounting for sex in adipose tissue

时间窗: During 36 months of analysis (after 60 months of inclusion)

Ultrasound and MRI images analysis of volumes of subcutaneous, visceral and epicardial adipose tissues

次要结局

  • Advanced Imaging profiling of Heart(During 36 months of analysis (after 60 months of inclusion))
  • Advanced imaging profiling in Liver(During 36 months of analysis (after 60 months of inclusion))
  • Advanced biological phenotyping(During 36 months of analysis (after 60 months of inclusion))
  • identification of genetic risk markers for cardio-metabolic diseases(During 36 months of analysis (after 60 months of inclusion))

研究者

发起方
Institut National de la Santé Et de la Recherche Médicale, France
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验